Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close

Make a donation

Thursday, April 22, 2021

Myeloma Matters: April 2021

  • Latest news
  • Isatuximab (Sarclisa, for injection) with carfilzomib (Kyrpolis) and dexamethasone: Take our survey!
  • Isatuximab (Sarclisa, for injection) with pomalidomide (Pomalyst) and dexamethasone: Final recommendation is out!
  • Can less treatment be better?
  • Help us get funding for a drug to treat graft versus host disease for patients in Canada
  • Announcing the 13th Annual Myeloma Canada Multiple Myeloma March!
  • Myeloma Peer Support Program has launched!
  • New InfoVideo is now online!
  • Myeloma Canada welcomes 3 new Board members
  • Spotlight on Trevor Ives
  • In the community
  • Upcoming events
  • COVID-19 related news

Read more...